ArticleJournal of thoracic disease2022
Development and validation of a combined metabolism and immune prognostic model in lung adenocarcinoma.
Yu Shi et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
1 paper cites it
this papercites it